Pandom / Pandom-SR
Pantoprazole 40 mg + Domperidone 10 mg / 30 mg SR
Clinical Differentiators & Advantages
PCD Franchise Distribution
Verify if exclusive marketing and distribution rights for Pandom / Pandom-SR are currently vacant in your target district.
Active Chemical Compounds & Molecular Architecture
Validated chemical entities, 2D skeletal bond diagrams, empirical molecular formulas, and receptor-level modes of action
Irreversibly inhibits proton pump to provide sustained 24-hour gastric acid suppression.
Prokinetic agent that accelerates gastric emptying and prevents nausea and reflux.
Approved Clinical Indications & Disease Burden
Pharmacodynamic Mechanism of Action
Dual-action acid-motility control: Pantoprazole irreversibly binds to and inhibits the gastric H+/K+ ATPase enzyme in parietal cells, halting gastric acid secretion. Domperidone acts as a peripheral dopamine D2 receptor antagonist, increasing lower esophageal sphincter tone and stimulating antral gastroduodenal motility to prevent retrograde reflux.
Dosage & Administration Protocol
1 tablet or capsule daily in the morning, 30 to 60 minutes before breakfast.
Precautions, Warnings & Contraindications
B2B Commercial & Shipping Metrics
Moisture-sealed 5-ply export corrugation
Includes visual aids & promotional inputs
Private label & institutional supply
Standard pharmaceutical commercial tariff
Certificate of Analysis (COA), Stability Study Reports (Zone IVb), Finished Product Specs (FPS), and Material Safety Data Sheet (MSDS).
Frequently Prescribed & Stocked Together
Clinically aligned formulations commonly co-prescribed with Pandom / Pandom-SR to improve patient outcomes and expand distributor portfolio basket size.
Rabicon / Rabicon-L
Rabeprazole Sodium 20 mg (± Levosulpiride 75 mg SR)
“Erases Acid, Regulates Motility — Greater Success in Reflux”